Diabetic Macular Edema

Showing NaN - NaN of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Repeated, In-Clinic, Self-Imaging by DME Patients Using Notal

Recruiting
  • Diabetic Macular Edema
  • Notal Vision Home OCT
  • Baltimore, Maryland
  • +2 more
Feb 15, 2023

Diabetic Macular Edema Trial in Puerto Rico, United States (Faricimab)

Recruiting
  • Diabetic Macular Edema
  • Mesa, Arizona
  • +43 more
Jan 31, 2023

Diabetic Macular Edema Trial in Puerto Rico, United States (CU06-1004)

Recruiting
  • Diabetic Macular Edema
  • Baltimore, Maryland
  • +9 more
Dec 13, 2022

Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • Mesa, Arizona
  • +184 more
Apr 1, 2022

Diabetic Macular Edema Trial in United States (Iluvien 0.19 MG Drug Implant, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +45 more
Jan 4, 2022

Diabetic Macular Edema Trial in United States (IVT aflibercept, Sham SC, SC CLS-TA)

Completed
  • Diabetic Macular Edema
  • IVT aflibercept
  • +2 more
  • Phoenix, Arizona
  • +28 more
Apr 22, 2021

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

Completed
  • AMD - Age-Related Macular Degeneration
  • Diabetic Macular Edema
  • Notal Vision Optical Coherence Tomography Device Version 2.5 (NOTAL-OCT V2.5)
  • Baltimore, Maryland
    Elman Retina Group, PA
Nov 10, 2020

Diabetic Macular Edema Trial in United States (Faricimab, Ranibizumab)

Completed
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +59 more
Aug 31, 2020

Diabetic Retinopathy, Diabetic Macular Edema Trial in Canada, United States (Pemafibrate, Placebo)

Terminated
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +70 more
Aug 27, 2020

Diabetic Macular Edema Trial in United States (2.0 mg intravitreal aflibercept, 1.25 mg intravitreal bevacizumab, 0.3 mg

Completed
  • Diabetic Macular Edema
  • 2.0 mg intravitreal aflibercept
  • +2 more
  • Tucson, Arizona
  • +89 more
Jul 22, 2020

Evaluation of Vitrectomy for Diabetic Macular Edema

Completed
  • Diabetic Retinopathy
  • Diabetic Macular Edema
    • Irvine, California
    • +47 more
    Sep 20, 2019

    Identifying Unrecognized Treatable Diabetic Macular Edema

    Unknown status
    • Diabetic Macular Edema
      • Baltimore, Maryland
      • +1 more
      Feb 6, 2019

      Diabetic Macular Edema Trial in United States (Luminate 1.0mg, Luminate 2.0mg, Luminate 3.0mg)

      Completed
      • Diabetic Macular Edema
      • Luminate 1.0mg
      • +4 more
      • Phoenix, Arizona
      • +16 more
      Dec 5, 2018

      Diabetic Macular Edema Trial in United States (REGN910-3, Intravitreal Aflibercept Injection (IAI))

      Completed
      • Diabetic Macular Edema
      • REGN910-3
      • Intravitreal Aflibercept Injection (IAI)
      • Mesa, Arizona
      • +50 more
      Oct 1, 2018

      Diabetic Macular Edema Trial in United States (intravitreal ranibizumab 0.3 mg, dexamethasone intravitreal implant, Sham

      Completed
      • Diabetic Macular Edema
      • intravitreal ranibizumab 0.3 mg
      • +2 more
      • Beverly Hills, California
      • +55 more
      Sep 24, 2018

      Diabetic Macular Edema Trial in United States (nepafenac 0.1% drops, Nepafenac Vehicle)

      Completed
      • Diabetic Macular Edema
      • nepafenac 0.1% drops
      • Nepafenac Vehicle
      • Loma Linda, California
      • +31 more
      Aug 21, 2018

      Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema Trial in United States (DS-7080a, Ranibizumab)

      Completed
      • Neovascular Age-Related Macular Degeneration
      • Diabetic Macular Edema
      • Phoenix, Arizona
      • +11 more
      May 8, 2018

      Diabetic Macular Edema Trial in Baltimore (ILUVIENĀ®)

      Withdrawn
      • Diabetic Macular Edema
      • Baltimore, Maryland
        Wilmer Eye Institute, Johns Hopkins University School of Medicin
      Aug 21, 2017

      Diabetic Macular Edema Trial in United States (Ranibizumab, ranibizumab)

      Completed
      • Diabetic Macular Edema
      • Beverly Hills, California
      • +12 more
      Mar 20, 2017

      Diabetic Macular Edema Trial in United States (Ranibizumab, Laser photocoagulation)

      Completed
      • Diabetic Macular Edema
      • Phoenix, Arizona
      • +19 more
      Mar 20, 2017

      Diabetic Macular Edema Trial in Worldwide (Ruboxistaurin, Placebo)

      Completed
      • Diabetic Macular Edema
      • Phoenix, Arizona
      • +40 more
      Aug 25, 2016

      Diabetic Macular Edema Trial in Baltimore (Dexamethasone Implant, Anti-VEGF injection)

      Completed
      • Diabetic Macular Edema
      • Dexamethasone Implant
      • Anti-VEGF injection
      • Baltimore, Maryland
        Wilmer Eye Institute
      Aug 23, 2016

      Diabetic Macular Edema Trial in United States (Efalizumab, Ranibizumab)

      Withdrawn
      • Diabetic Macular Edema
      • Tucson, Arizona
      • +9 more
      Aug 25, 2016

      The Course of Response to Focal Photocoagulation for DME

      Completed
      • Diabetic Retinopathy
      • Diabetic Macular Edema
      • Laser photocoagulation
      • Palm Springs, California
      • +31 more
      Aug 25, 2016

      Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in United States (drug, behavioral, procedure)

      Completed
      • Proliferative Diabetic Retinopathy
      • Diabetic Macular Edema
      • Artesia, California
      • +55 more
      Aug 25, 2016